Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Ting Gan

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Therapeutics|February 16, 2026
Tislelizumab-Associated VitiligoYu-Ting Gan, Jia-Luo Cai
American Journal of Therapeutics|November 4, 2025
JAK Inhibitors in the Treatment of Hailey-Hailey Disease: A Case Series and Mechanistic ExplorationYu-Ting Gan, Yuan-Fang Wan, Bing-Jun Shi
International Journal of Dermatology|January 27, 2026
Tofacitinib for Acquired Reactive Perforating Collagenosis: A Retrospective Study of Efficacy and SafetyYu-Ting Gan, Shi Yan, Yi Liu, et al.
American Journal of Therapeutics|June 15, 2026
Tofacitinib for Pigmented Purpuric Dermatoses: Subtype-Specific Therapeutic Responses and Clinical ImplicationsYu-Ting Gan, Shi Yan, Yi Liu, et al.
American Journal of Therapeutics|June 15, 2026
Salvage Therapy With Upadacitinib for Tofacitinib-Refractory Scarring Alopecia in an Asian Patient: Role of JAK1 Selective InhibitionYu-Ting Gan, Shi Yan, Yi Liu, et al.
International Journal of Dermatology|October 11, 2025
Tofacitinib for Urticarial Vasculitis: A Retrospective Study of 13 PatientsYu-Ting Gan, Shi Yan, Yi Liu, et al.
American Journal of Therapeutics|February 27, 2026
Tofacitinib in Pigmented Purpuric DermatosesYu-Ting Gan, Xing-Ying Liu, Hua Liu, et al.
Frontiers in Immunology|February 16, 2026
Severe DRESS syndrome with hemophagocytic lymphohistiocytosis and cryptococcal meningitis: a case report and diagnostic challengeShi Yan, Yu-Ting Gan, Jia-Jia Li, et al.
Dermatology Practical & Conceptual|March 30, 2026
From Misdiagnosis to Molecular Insight: Lessons from Two ARCI Siblings Initially Treated as Netherton SyndromeShi Yan, Yu-Ting Gan, Yan-Wen Liu, et al.
American Journal of Therapeutics|June 15, 2026
Upadacitinib as a Successful Sequential Therapy After Abrocitinib Failure in a Patient With Refractory Darier DiseaseYu-Ting Gan, Shi Yan, Wei-Na Xie, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Therapeutics|February 16, 2026
Tislelizumab-Associated VitiligoYu-Ting Gan, Jia-Luo Cai
American Journal of Therapeutics|November 4, 2025
JAK Inhibitors in the Treatment of Hailey-Hailey Disease: A Case Series and Mechanistic ExplorationYu-Ting Gan, Yuan-Fang Wan, Bing-Jun Shi
International Journal of Dermatology|January 27, 2026
Tofacitinib for Acquired Reactive Perforating Collagenosis: A Retrospective Study of Efficacy and SafetyYu-Ting Gan, Shi Yan, Yi Liu, et al.
American Journal of Therapeutics|June 15, 2026
Tofacitinib for Pigmented Purpuric Dermatoses: Subtype-Specific Therapeutic Responses and Clinical ImplicationsYu-Ting Gan, Shi Yan, Yi Liu, et al.
American Journal of Therapeutics|June 15, 2026
Salvage Therapy With Upadacitinib for Tofacitinib-Refractory Scarring Alopecia in an Asian Patient: Role of JAK1 Selective InhibitionYu-Ting Gan, Shi Yan, Yi Liu, et al.
International Journal of Dermatology|October 11, 2025
Tofacitinib for Urticarial Vasculitis: A Retrospective Study of 13 PatientsYu-Ting Gan, Shi Yan, Yi Liu, et al.
American Journal of Therapeutics|February 27, 2026
Tofacitinib in Pigmented Purpuric DermatosesYu-Ting Gan, Xing-Ying Liu, Hua Liu, et al.
Frontiers in Immunology|February 16, 2026
Severe DRESS syndrome with hemophagocytic lymphohistiocytosis and cryptococcal meningitis: a case report and diagnostic challengeShi Yan, Yu-Ting Gan, Jia-Jia Li, et al.
Dermatology Practical & Conceptual|March 30, 2026
From Misdiagnosis to Molecular Insight: Lessons from Two ARCI Siblings Initially Treated as Netherton SyndromeShi Yan, Yu-Ting Gan, Yan-Wen Liu, et al.
American Journal of Therapeutics|June 15, 2026
Upadacitinib as a Successful Sequential Therapy After Abrocitinib Failure in a Patient With Refractory Darier DiseaseYu-Ting Gan, Shi Yan, Wei-Na Xie, et al.
Pageof 2